Steatohepatitis/Metabolic Liver Disease

Top Story

Gilead joins ongoing NASH, HBV observational study initiative

November 20, 2018
Meeting NewsVideo

VIDEO: New NAFLD data guide treatment, improve survival

November 20, 2018
SAN FRANCISCO — In this exclusive video perspective from The Liver Meeting 2018, Zobair M. Younossi, MD, chairman of the department of medicine at Inova Fairfax…

NIH grants $2.4 million to research impact of nervous system on NAFLD

November 19, 2018
Researchers from George Washington University received a grant of approximately $2.4 million from the National Institutes of Health to investigate the role of forebrain…
Meeting NewsVideo

VIDEO: Echosens discusses future of Fibroscan with new biomarkers

November 16, 2018
SAN FRANCISCO — In this exclusive video from The Liver Meeting 2018, Sven Henrichwark, CEO of Echosens, discusses the company’s Fibroscan technology and the…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

DDW 2018 review: Obesity treatment integral to gastroenterology care

June 20, 2018
More »